AstraZeneca’s Covid-19 vaccine has generated $275 million in sales so far this year.
The company has pledged not to profit from its vaccine during the pandemic. Governments have been paying several dollars per dose.
Full Article
AstraZeneca’s Covid-19 vaccine has generated $275 million in sales so far this year.
NYTimes.com
0 shares
2 views
You might like
Related news coverage
AstraZeneca Delivers COVID Vaccines To EU and U.K.
Newsy
Watch VideoAstraZeneca said it delivered roughly 68 million doses of the COVID-19 vaccine over the first three months of the..
Advertisement
More coverage
EU Sues AstraZeneca Over Delayed Vaccine Deliveries
Newsy
Watch VideoThe EU is suing AstraZeneca over its vaccine contract.
The European Commission says the vaccine maker failed..
-
Indonesia on alert to avert India-like viral wave
MENAFN.com
-
AstraZeneca hits sales of nearly £200m from Covid-19 jabs
Belfast Telegraph
-
Brazil's Q1 2021 exports to Arab world soar USD 2.91 billion amid global trade recovery
MENAFN.com
-
FTSE 100 little changed despite resurgence of aerospace-related stocks
Proactive Investors